A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American brain tumor consortium study. (vol 2, pg 34, 2000) Other Scholarly Work

cited authors

  • Schold, SC; Kuhn, JG; Chang, SM; Bosik, ME; Robins, HI; Mehta, MP; Spence, AM; Fulton, D; Fink, KL; Prados, MD

sustainable development goals

authors

publication date

  • April 1, 2001

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

WoS ID

  • 000167749600006

start page

  • 123

end page

  • 123

volume

  • 3

issue

  • 2